These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29127908)

  • 1. Development and validation of a stability-indicating HPLC-UV method for the determination of triamcinolone acetonide and its degradation products in an ointment formulation.
    van Heugten AJP; de Boer W; de Vries WS; Markesteijn CMA; Vromans H
    J Pharm Biomed Anal; 2018 Feb; 149():265-270. PubMed ID: 29127908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a stability-indicating HPLC-UV method for the determination of Thiocolchicoside and its degradation products.
    Aprile S; Canavesi R; Bianchi M; Grosa G; Del Grosso E
    J Pharm Biomed Anal; 2017 Jan; 132():66-71. PubMed ID: 27697571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of methylparaben, propylparaben, triamcinolone acetonide and its degradation product in a topical cream by RP-HPLC.
    Matysová L; Hájková R; Sícha J; Solich P
    Anal Bioanal Chem; 2003 Jun; 376(4):440-3. PubMed ID: 12819846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Excipients in the Stability of Triamcinolone Acetonide in Ointments.
    van Heugten AJP; de Vries WS; Markesteijn MMA; Pieters RJ; Vromans H
    AAPS PharmSciTech; 2018 Apr; 19(3):1448-1453. PubMed ID: 29450828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a stability-indicating HPLC-UV method for the determination of alizapride and its degradation products.
    Tamaro I; Aprile S; Giovenzana GB; Grosa G
    J Pharm Biomed Anal; 2010 Apr; 51(5):1024-31. PubMed ID: 19962264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability-indicating HPLC method for the determination of cefquinome sulfate.
    Dołhań A; Jelilńska A; Manuszewska M
    Acta Pol Pharm; 2014; 71(2):249-54. PubMed ID: 25272644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
    Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
    J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution and Quantitation of Triamcinolone Acetonide and Its Coformulated Drug in the Presence of Its Impurities and Degradation Products by HPTLC and HPLC.
    Abbas SS; Hegazy MA; Hendawy HAM; Weshahy SA; Abdelwahab MH
    J AOAC Int; 2018 Jul; 101(4):981-991. PubMed ID: 28903833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a stability- indicating HPLC method for simultaneous determination of ten related substances in vonoprazan fumarate drug substance.
    Luo Z; Liu A; Liu Y; Wang G; Chen X; Wang H; Li M; Zhang H; Qiu Y; Zhai H
    J Pharm Biomed Anal; 2018 Feb; 149():133-142. PubMed ID: 29112902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DEVELOPMENT AND VALIDATION OF THE STABILITY-INDICATING LC-UV METHOD FOR DETERMINATION OF CEFOZOPRAN HYDROCHLORIDE.
    Zalewski P; Garbacki P; Cielecka-Piontek J; Bednarek-Rajewska K; Krause A
    Acta Pol Pharm; 2015; 72(3):423-7. PubMed ID: 26642650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of azide impurity in sartans using reversed-phase HPLC with UV detection.
    Gričar M; Andrenšek S
    J Pharm Biomed Anal; 2016 Jun; 125():27-32. PubMed ID: 26999319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms.
    El Karbane M; Azougagh M; Amood A L-Kamarany M; Bouchafra H; Cherrah Y; Bouklouze A
    Ann Pharm Fr; 2014 Jul; 72(4):244-55. PubMed ID: 24997886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation.
    Reddy PS; Sudhakar Babu K; Kumar N
    J Chromatogr Sci; 2013 Mar; 51(3):242-9. PubMed ID: 22988002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using an innovative Quality-by-Design approach for development of a stability indicating UHPLC method for ebastine in the API and pharmaceutical formulations.
    Schmidt AH; Molnár I
    J Pharm Biomed Anal; 2013 May; 78-79():65-74. PubMed ID: 23454599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A stability-indicating HPLC method for simultaneous determination of morphine and naltrexone.
    Jafari-Nodoushan M; Barzin J; Mobedi H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1011():163-70. PubMed ID: 26773883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
    Kumar N; Sangeetha D; Reddy SP
    J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a stability-indicating HPLC method of etifoxine with characterization of degradation products by LC-MS/TOF, 1H and 13C NMR.
    Djabrouhou N; Guermouche MH
    J Pharm Biomed Anal; 2014 Nov; 100():11-20. PubMed ID: 25117950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability-indicating HPLC method for acyclovir and lidocaine in topical formulations.
    Mulabagal V; Annaji M; Kurapati S; Dash RP; Srinivas NR; Tiwari AK; Babu RJ
    Biomed Chromatogr; 2020 Mar; 34(3):e4751. PubMed ID: 31756271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a stability-indicating HPLC assay method for simultaneous determination of spironolactone and furosemide in tablet formulation.
    Ram VR; Dave PN; Joshi HS
    J Chromatogr Sci; 2012 Sep; 50(8):721-6. PubMed ID: 22641089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.